News
Beta Drugs consolidated net profit rises 0.22% in the March 2026 quarter
14-May-2026 | 18:00
Sales rise 0.21% to Rs 93.96 crore
Net profit of Beta Drugs rose 0.22% to Rs 9.05 crore in the quarter ended March 2026 as against Rs 9.03 crore during the previous quarter ended March 2025. Sales rose 0.21% to Rs 93.96 crore in the quarter ended March 2026 as against Rs 93.76 crore during the previous quarter ended March 2025.
For the full year,net profit declined 2.22% to Rs 41.48 crore in the year ended March 2026 as against Rs 42.42 crore during the previous year ended March 2025. Sales rose 6.20% to Rs 384.83 crore in the year ended March 2026 as against Rs 362.36 crore during the previous year ended March 2025.
| Particulars | Quarter Ended | Year Ended | ||||
| Mar. 2026 | Mar. 2025 | % Var. | Mar. 2026 | Mar. 2025 | % Var. | |
| Sales | 93.96 | 93.76 | 0 | 384.83 | 362.36 | 6 |
| OPM % | 18.82 | 18.50 | - | 19.67 | 20.59 | - |
| PBDT | 16.63 | 18.02 | -8 | 71.55 | 74.05 | -3 |
| PBT | 11.83 | 14.45 | -18 | 54.39 | 61.54 | -12 |
| NP | 9.05 | 9.03 | 0 | 41.48 | 42.42 | -2 |
Powered by Capital Market - Live News
